FDA
U.S. Food and Drug Administration
U.S. Food & Drug Administration
PR-10-24-NI-44Oct 14, 2024
FDA
FDA Approves IMULDOSA, Accord BioPharma's Biosimilar to STELARA, for the Treatment of Chronic Inflammatory Conditions
Accord Biopharma
PR-10-24-NI-43Oct 14, 2024
FDA
SystImmune, Inc. Announces FDA Clearance of IND Application for BL-M11D1 in Relapsed/Refractory Acute Myeloid Leukemia
Systimmune, Inc.
PR-10-24-NI-42Oct 14, 2024
CDMO
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development
Samsung Biologics
PR-10-24-NI-41Oct 14, 2024
Appointment
Prime Therapeutics bolsters its position as industry leader with 10 research studies at AMCP Nexus 2024
Prime Therapeutics
PR-10-24-NI-40Oct 11, 2024
Clinical Trials
Harbour BioMed Announces the Phase I Study Results in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors
Harbour BioMed
PR-10-24-NI-39Oct 11, 2024
Large Molecule
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
Waters Corporation
PR-10-24-NI-38Oct 11, 2024
CDMO
Revolutionary CDMO Wheeler Bio Appoints Patrick Lucy as CEO
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-24-CL-08Oct 11, 2024
ADC
World ADC San Diego Celebrates 15th Anniversary With Industry-Leading Agenda
World ADC
PR-10-24-NI-37Oct 10, 2024
Announcement
Genezen Appoints Mike Wourms as Chief Operations Officer
Genezen
PR-10-24-NI-36Oct 08, 2024
Clinical Trials
StemCyte's HPC Cord Blood Receives RMAT Designation for Long COVID-19 Treatment
StemCyte
PR-09-24-NI-28Oct 07, 2024
Clinical Trials
Soligenix Announces Partnership with Sterling Pharma Solutions
Soligenix, Inc.
PR-09-24-NI-32Oct 07, 2024
Clinical Trials
HyBryte™ expanded treatment results to be presented at the European Organisation for research and treatment of cancer conference
Soligenix, Inc.
PR-10-24-NI-33Oct 07, 2024
Clinical Development
Anixa Biosciences appoints Suyasha Gupta as Senior Director of Clinical Development
Anixa Biosciences
PR-10-24-NI-34Oct 07, 2024
Cell Therapy
Cryoport launches its IntegriCell™ cryopreservation solution with opening of new facility at its Houston Campus
Cryoport
PR-10-24-NI-35Oct 07, 2024
Financing
Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx for ENHANZE
Halozyme Therapeutics
PR-09-24-NI-31Oct 04, 2024
FDA
Thryv Therapeutics Granted FDA Orphan Drug Designation for LQT-1213 in Long QT Syndrome Treatment
Thryv Therapeutics Inc
PR-09-24-NI-27Oct 03, 2024
FDA
PTC Therapeutics Announces FDA Acceptance for Filing of NDA for the Treatment of Pediatric and Adult Phenylketonuria Patients
PTC Therapeutics, Inc.
PR-09-24-NI-26Oct 03, 2024
Innovation
SGD Pharma presents new optimized solutions at CPHI worldwide 2024, continuing its leadership in sustainability and innovation
SGD Pharma
PR-09-24-NI-25Oct 01, 2024
Financing
Piramal Pharma Solutions Announces $80M Expansion Plan for Sterile Injectables Facility in Lexington, Kentucky
Piramal Pharma Ltd.
PR-09-24-NI-24Sep 30, 2024